Carbapenem-Resistant Klebsiella Pneumoniae in Barbados: Driving Change in Practice at the National Level. by Forde, Corey et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Psychiatry and Behavioral Sciences Faculty
Publications Psychiatry and Behavioral Sciences
1-1-2017
Carbapenem-Resistant Klebsiella Pneumoniae in
Barbados: Driving Change in Practice at the
National Level.
Corey Forde
Bryan Stierman
Pilar Ramon-Pardo
Thais Dos Santos
Nalini Singh
George Washington University
Follow this and additional works at: http://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs
Part of the Bacteriology Commons
This Journal Article is brought to you for free and open access by the Psychiatry and Behavioral Sciences at Health Sciences Research Commons. It has
been accepted for inclusion in Psychiatry and Behavioral Sciences Faculty Publications by an authorized administrator of Health Sciences Research
Commons. For more information, please contact hsrc@gwu.edu.
APA Citation
Forde, C., Stierman, B., Ramon-Pardo, P., Dos Santos, T., & Singh, N. (2017). Carbapenem-Resistant Klebsiella Pneumoniae in
Barbados: Driving Change in Practice at the National Level.. PLoS One, 12 (5). http://dx.doi.org/10.1371/journal.pone.0176779
RESEARCH ARTICLE
Carbapenem-resistant Klebsiella pneumoniae
in Barbados: Driving change in practice at the
national level
Corey Forde1*, Bryan Stierman2, Pilar Ramon-Pardo3, Thais dos Santos3, Nalini Singh2,4*
1 Queen Elizabeth Hospital, Bridgetown, Barbados, 2 Children’s National Health System, Washington DC,
United States of America, 3 Pan American Health Organization, Washington DC, United States of America,
4 George Washington University, Washington DC, United States of America
* nsingh@childrensnational.org (NS); cfordeclinic@gmail.com (CF)
Abstract
Introduction
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is of growing concern globally. The
risk for transmission of antimicrobial resistant organisms across several continents to the
Caribbean is a real one given its tourism industry. After a cluster of cases of CRKP were
detected, several studies detailed in this report were initiated to better characterize the
problem.
Methods
A hospital-wide point prevalence study and active surveillance were performed at Queen
Elizabeth Hospital (QEH) in Barbados in 2013 to assess the prevalence of CRKP infection/
colonization. Following this, a 1-year longitudinal study measured the prevalence of CRKP
isolates in the hospital and across all healthcare facilities in the country.
Results
In 2013, eleven viable isolates of CRKP from cluster of cases were sent for molecular epide-
miology studies. When sequenced, they were found to be the ST-258 clone. Identification of
a cluster of cases of CRKP ST-258/512 clones indicated person-to-person transmission. In
September 2013, the hospital-wide point prevalence study revealed 18% of patients (53/
299) at the hospital were either colonized or infected with CRKP. The infection to coloniza-
tion ratio was 1:7. Patients who were infected/colonized vs. non-colonized were older (64.7
vs. 48.7 years, p<0.0001), were hospitalized longer (42.5 days vs. 27 days, p = 0.0042),
were more likely to have an invasive device (66% vs. 32%, p<0.0001), especially urinary
catheters (55% vs. 24%, p<0.0001), and were more likely to have used antimicrobials within
the prior 14 days (91% vs. 46%, p<0.0001). Specific antimicrobials, including fluoroquino-
lones and piperacillin-tazobactam, were significantly associated with infection/colonization.
In 2014, the 12-month period prevalence of CRKP in Barbados was 49.6 per 100,000 popu-
lation and of blood stream infections was 3.2 per 100,000 population.
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Conclusions
This point prevalence study identified patients at-risk of acquisition of CRKP and allowed
QEH to implement interventions aimed at decreasing the prevalence of CRKP. Organization
of a National and regional Infection Prevention and Control Committee in 2014 aimed to
strengthen antimicrobial resistance surveillance programs across the English-speaking
Caribbean were established.
Introduction
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is of growing concern globally with spo-
radic cases as well as epidemics reported in numerous countries spanning multiple continents
across the world [1–7]. CRKP is a critical priority organism in the World Health Organiza-
tion’s global priority list of antimicrobial resistant bacteria, which is meant to guide research,
discovery and development of new antimicrobials, and global antimicrobial resistance surveil-
lance [8,9]. CRKP is associated with increased morbidity and mortality in the hospital setting
in part due to the limited treatment options available [3]. Varying risk factors have been associ-
ated with CRKP colonization, including organ or stem cell transplant, mechanical ventilation,
tracheostomy, nasogastric tube, fecal incontinence, length of hospital stay, and exposure to
certain antimicrobials [2,4,5,10,11]. A cluster of cases of CRKP was reported across multiple
patient care units of the Queen Elizabeth Hospital (QEH) in Barbados, revealing concern for a
widespread problem. The Ministry of Health in Barbados sought consultation from the Pan
American Health Organization for support in further investigation. In 2013, molecular epide-
miology of 11 of the 17 viable samples showed a dominant clone and the possibility of person-
to-person transmission within a healthcare setting (Fig 1). The aim of this study is to report
the point-prevalence of colonization/infection with CRKP at QEH and the subsequent results
of a 1-year longitudinal study on the incidence of CRKP infections in the country.
Materials and methods
Setting
Queen Elizabeth Hospital is the only public hospital in Barbados and serves as the referral hos-
pital for a population of 250,010 (119,926 males and 130,084 females). It is a 600-bed public hos-
pital that averages an occupancy rate of 70%, with inpatient wards serving general acute care,
intensive care (ICU), high dependency care, surgical care, obstetrics and gynecology, and pedi-
atrics as well as outpatient services. The region’s geriatric and psychiatric hospitals also send
patients to QEH. It offers free medical services to all Barbadian nationals and caters medical
services to several other countries within the English speaking Caribbean region, on demand.
QEH Human Subject Research and Ethics Board approved the point prevalence study done in
Sept 2013. Verbal consent was obtained at the time of taking the rectal swab for the point preva-
lence study. If patients refused or had some other reasoning for a lack of participation this was
documented in the information sheet.
Case definition
CRKP was defined using the Clinical Laboratory Standards Institute (CLSI) as isolation of
Klebsiella pneumoniae 1) not susceptible to at least one of the following carbapenems: ertape-
nem, imipenem, meropenem, or doripenem and 2) resistant to all tested third-generation
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cephalosporins including ceftriaxone, cefotaxime, and ceftazidime [12]. A case was considered
colonized when CRKP was isolated from the rectal swab and considered infected when the
patient exhibited clinical signs of infection and culture revealed CRKP.
Study design
After an initial investigation of a cluster of cases in 2013, a hospital-wide point prevalence
study was conducted on a single day in September 2013 across 26 patient care units/wards,
containing a total of 311 patients. A total of 299 patients were included in the analysis. On this
day, there were 6 known cases of infection with CRKP in one unit, an isolation ward, as well as
1 case in the surgical intensive care unit. These known cases were included in the analysis.
Eight people who refused rectal swab and 4 patients who were transferred off the unit at the
time of swab collection were excluded from analysis. Upon completion of the point-prevalence
study, surveillance was carried out for the 12-month period in 2014 to assess the prevalence of
CRKP using the CDC’s case-based surveillance definition [13].
Specimen and data collection
Medical staff were educated by the hospital infection prevention control (IPC) team on the
correct procedure for rectal swab collection. Rectal swabs were then collected from each
patient included in the study. Twenty-one link staff nurses and three IPC nurses on each ward
were charged with obtaining verbal consent. Upon collection, swabs were transferred to the
onsite microbiology laboratory for processing. CRKP was identified in the microbiology labo-
ratory in Barbados by culture, using the Modified Hodge test. CLSI minimum inhibitory con-
centration breakpoints were used [12]. Patient data was collected on a standardized form with
the following information obtained at the time of the rectal swab collection: age, gender, ward,
ICU status, length of stay in hospital prior to date of swab collection, use of antimicrobials
Fig 1. PFGE for molecular typing of selected samples showing similarities in band patterns across
each sample.
https://doi.org/10.1371/journal.pone.0176779.g001
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within 14 days prior to swab collection, use of invasive devices within 30 days prior to swab
collection, and medical co-morbidities. Patients were classified as infected or colonized using
the CDC surveillance definition [14]. Following the point-prevalence study, specimens positive
for CRKP were tracked throughout QEH and other health care facilities in Barbados during
the 12 month period in 2014. This data was used to calculate the prevalence of CRKP at QEH
as well as in the population of Barbados. In 2013, 11 viable samples from the cluster of 17 cases
from different units and patients were sent via the Caribbean Public Health Agency to the
regional laboratory at Malbran National Institute of Infectious Diseases in Argentina where
pulsed field gel electrophoresis (PFGE) was used for molecular typing (CHEF-DRIII). Tenover
criteria were used to classify organisms as indistinguishable, closely related, possibly related or
different [15]. Briefly, the restriction enzyme used was XbaI. The allelic variant of the KPC
(Klebsiella pneumoniae carbapenemase) gene was determined by sequencing of the PCR prod-
uct by the method of Sanger, using the BigDye Terminator Applied Biosystem methodology.
The nucleotide sequence was analyzed using the DNASTAR computational software package,
in addition to Chromas, ClustalX, and others programs with free access such as BLAST and
PROSITE (National Center for Biotechnology Information, Bethesda, MD). The genetic envi-
ronment of the KPC gene was determined by PCR mapping [16,17].
Statistics
Data analyses were carried out with EpiInfo7.1.5 (Centers for Disease Control and Prevention,
Atlanta, GA). The χ2 test or Fisher Exact test were used to evaluate associations between CRKP
colonized patients and categorical variables. The Wilcoxon rank-sum test was used to evaluate
associations between CRKP colonized patients and continuous variables. Binomial logistic
regression was performed with all predictors to control for any confounding by other vari-
ables. EpiInfo uses the Newton-Raphson method for maximizing likelihood in logistic regres-
sion. Conditional mean imputation was used to average cases and non-cases separately and
replace missing values for the logistic regression analysis. Incidence and prevalence measures
were calculated using standard definitions.
Results
During the hospital-wide point-prevalence study in September 2013 in 26 wards, a total of 53
(18%) patients were found to be colonized or infected and 246 (82%) were not colonized. Of
these, 7 were active infections and 46 were colonized patients, giving an infection to coloniza-
tion ratio of 1:7. Of the infected patients, 3 had bacteremia and 4 had urinary tract infections.
One patient with a urinary tract infection progressed to have bacteremia. Several factors were
significantly associated with colonization/infection with CRKP (Table 1). Patients who were
colonized/infected were older, 64.7 years old, compared to those not colonized/not infected,
48.7 years old (p<0.0001). Patients who were colonized/infected on average were in the hospi-
tal longer, 42.5 days, vs. non-infected, 27 days (p = 0.0042). Invasive devices were also signifi-
cantly associated with colonization/infection. Those colonized/infected were more likely to
have an invasive device (p<0.0001), especially urinary catheters (p<0.0001), compared to
those who were not colonized/not infected. Antimicrobials were used more often within the
last 2 weeks (90.6% vs. 45.9%, p<0.0001) and in higher quantities (2.1 vs. 0.9, p<0.0001) in col-
onized/infected patients compared to controls.
The classes of antimicrobials used in colonized/infected vs. non-colonized/non-infected
patients were variable with significant increases in usage of fluoroquinolones and piperacillin-
tazobactam among those colonized/infected (p<0.05). Patients located in the High Depen-
dency Unit were more likely to be colonized/infected than others (p = 0.0008). Comorbidities,
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diabetes, hypertension, chronic kidney disease, devices like, mechanical ventilation, NG tube,
invasive vascular lines, and surgical drains were not found to be significantly associated with
colonization/infection. After controlling for each variable through logistic regression analysis,
older age (OR = 1.03, p = 0.016), length of stay>10 days (OR = 2.30, p = 0.034), presence of
invasive devices (OR = 3.36, p = 0.0022), and use of antimicrobials (OR = 12.08, p<0.0001)
remained significant predictors of colonization/infection with CRKP (Table 2). The crude
mortality rate after 7 days from specimen collection was 130 per 1000 patients for cases that
were colonized/infected compared to 70 per 1000 patients for those not infected.
Molecular typing was performed on 11 viable samples which were confirmed as carbapene-
mase producers by Modified Hodge test. Isolates showed similar Isolates showed similar sus-
ceptibility patterns. PFGE was used for molecular typing, utilizing the restriction enzyme
XbaI, and revealed that samples were genetically related with 7 subtypes of the same clonal
type based on analysis using the Tenover criteria [15]. The allelic variant of the KPC gene was
established as KPC-3 in the transposon Tn4401a, which has been globally associated with the
KPC-K. pneumoniae ST258 epidemic clone (Fig 1). All samples tested positive by PCR for
PILV-like protein (pilv-l) and 10 of 11 were PCR prp positive. Sequencing allowed for molecu-
lar typing which revealed isolates were of the ST-258 clone.
Table 1. Characteristics of CRKP positive patients from point prevalence study.
Characteristics Case (n = 53), n (%) Non-Cases (n = 246), n (%) p
Gender Female 30 (56.6%) 153 (62.2%) 0.45
Age (years) Mean (Min, Median, Max) 64.7 (26,65,95) 48.7 (0,49,102) <0.0001a
Length of Stay Mean (Min, Median, Max) 42.5 (1,15,746) 27.0 (1,8,410) 0.0042a
>10 days 36 (67.8%) 113 (46.1%) 0.0040a
Invasive Devices Mean Number of Devices (Min, Median, Max) 1.02 (0,1,5) 0.51 (0,0,5) <0.0001a
Any Device 35 (66.0%) 78 (31.7%) <0.0001a
Urinary cath 29 (54.7%) 60 (24.4%) <0.0001a
Mechanical Ventilation 2 (3.8%) 12 (4.9%) 1.00
Nasogastric Tube 11 (20.8%) 29 (11.8%) 0.082
Invasive Vascular Line 7 (13.2%) 18 (7.3%) 0.17
Antimicrobials On Antimicrobials 48 (90.6%) 113 (45.9%) <0.0001a
Mean Number of Antimicrobials (Min, Median, Max) 2.1 (0,2,6) 0.9 (0,0,6) <0.0001a
Location In Intensive Care Unit 5 (9.4%) 1 (0.4%) 0.00077a
Min, Minimum; Max, Maximum; Urinary Catheter; Nasogastric Tube, Intensive Care Unit
ap 0.05 considered significant
https://doi.org/10.1371/journal.pone.0176779.t001
Table 2. Logistic regression analysis of CRKP in point prevalence study.
Variable Odds Ratio 95% Confidence Interval P-Value
Gender (Male = 0) 0.86 (0.41–1.81) 0.69
Age (Continuous variable) 1.03 (1.00–1.05) 0.016a
Length of Stay >10 Days (No = 0) 2.30 (1.06–4.97) 0.034a
Invasive Device Present? (No = 0) 3.36 (1.55–7.28) 0.0022a
Any Antimicrobial Used (No = 0) 12.08 (4.35–33.50) <0.0001a
ap 0.05 considered significant
https://doi.org/10.1371/journal.pone.0176779.t002
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The point prevalence study completed in September 2013 was followed by a 1-year longitu-
dinal study of CRKP in 2014 at QEH and other Barbados health care sites. The peak incidence
of CRKP occurred in the month of July with 1.4 infections per 100 admissions. The lowest
incidence occurred in December with an incidence of 0.16 infections per 100 admissions (Fig
2). World Health Organization’s core components of infection prevention and control were
implemented in a step-wise manner after the detection of an outbreak. In 2014, a 1 year-long
prevalence for CRKP in health-care settings in Barbados was 49.6 per 100,000 population and
incidence of blood stream infection was 3.2 per 100,000 population.
Discussion
Results of our study show that several factors were associated with an increased risk of acquisi-
tion of CRKP, including location in the High Dependency Unit, increased antimicrobial
usage, and placement of urinary catheters. Elderly patients had a long length of stay within the
hospital and often remained within the hospital for social care prior to transfer to limited
capacity long care institutions, likely contributing to the prevalence of CRKP. To mitigate the
challenge of the high prevalence of CRKP, the World Health Organization’s core components
of Infection Control and Prevention and management of urinary catheters were implemented
[18]. This study draws attention to a focus on management and use of urinary catheters in a
resource-limited setting. Adherence to appropriate use can help to reduce catheter-associated
urinary tract infections [19]. Training at all levels of healthcare workers was instituted to help
define the indication and use of devices and urinary catheters for non-ICU patients. In Barba-
dos, non-ICU patients often required urinary catheters due to benign prostate hypertrophy or
after cerebrovascular accidents awaiting either surgical intervention or rehabilitation.
There is small but growing body of literature on carbapenemases from countries in the
Caribbean including Cuba, Guadeloupe, Trinidad and Tobago, and Puerto Rico [20,21]. KPC-3
specifically has been documented in Acinetobacter species in Puerto Rico but not in other Carib-
bean nations [22]. This study adds to the minimal body of current literature on carbapenemases
Fig 2. Incidence of CRKP in 2014.
https://doi.org/10.1371/journal.pone.0176779.g002
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in the English-speaking Caribbean, and specifically is one of the first to address KPC and CRKP
[21]. In addition, this study further highlights the presence and person-to person transmission
of the dominant worldwide clone ST-258. Molecular epidemiology of the select viable samples
showed a dominant clone and the possibility of person-to-person transmission within a health-
care setting.
Limitations of the 2013 point prevalence study include mortality data limited to the follow-
up time within one month after the swab collection and tracking of antimicrobial use limited
to the 14 days prior to swab collection. Resource limitations prevented the ability to analyze all
positive isolates with PFGE. Lack of prospectively collected data prevented tracking of the col-
onization to infection ratio or other further metrics in the 2014 prevalence study.
As a result of the findings of this study a national action has been implemented for screen-
ing for CRKP with rectal swabs in all patients who are in the hospital for longer than a month.
This study highlights, for one of the first times in literature, the spread of CRKP in long-term
and acute care facilities patients in a resource limited setting. Patients who were colonized/
infected were in the hospital longer, highlighting the impact of length of stay on risk of acquisi-
tion and person-to-person transmission. Resource limited settings like Barbados have a limited
capacity of long-term care facilities (24 beds) leading to the intermingling of acute and long
care based patients. This necessitates the screening of long care patients in these settings.
Surveillance cultures have been used to achieve successful reduction in CRKP infections [23,24].
Thus, admission and weekly rectal swab screening for patients in the HDU and all the ICUs in the
hospital was initiated as these were recognized from the study to be high risk areas [10].
The use of antimicrobials (especially fluoroquinolones) was a predictor of rectal CRKP car-
riage based on this study. In the hospital, there were no policies guiding the use of carbape-
nems and there was no formal antimicrobial stewardship program (ASP). The hospital
instituted an ASP which was highlighted in the January 2017 WHO AMR newsletter [25].
Tourism is one of the Caribbean’s major economic sectors, with over 20 million visitors
contributing $51.9 billion towards the area’s gross domestic product in 2014, which repre-
sented 14.6% of its total GDP [26]. Barbados remains a top tourist destination and in 2014 saw
519,601 long stay visitors and 557,898 cruise ship passenger visitors [27]. The risk for transmis-
sion of AMR organisms across several continents to the Caribbean bears interest. The distribu-
tion of the major AMR organisms such as Methicillin-resistant Staphylococcus aureus (MRSA)
clones in the French (Guadeloupe and Martinique) and non-French territories (Jamaica and
Trinidad and Tobago) were shown to be different. The clones most closely resembled those
found in the home countries of the travelers who visit the islands [28]. This implies the poten-
tial that the distribution of AMR is affected by tourist migration and further reveals the impor-
tance of this study.
Following initial findings, Barbados is establishing program consistent with the recently
described approach of containment of resistant gram-negative organisms in low resource set-
tings [29]. Measuring the prevalence of CRKP in Barbados has helped drive change in practice
and policy at the hospital level through the start of a formal Infection Prevention and Control
(IPC) program, at the national level via the commencement of a National IPC Committee, and
in the Caribbean region through mentorship programs in IPC and ASP of other English-speak-
ing Caribbean countries including Saint Vincent and the Grenadines, Saint Lucia, Grenada,
and Saint Kitts and Nevis. Barbados, following the outbreak, started a regional IPC conference
held yearly from 2014 with an aim to set up a regional surveillance system for AMR [25].
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